HIV in 2026: Four Experts on Aging, Testing, Equity, and Prevention's Next Era

For Contagion's HIV Awareness Month series, four clinicians and researchers across the spectrum of HIV care—a researcher studying ART-associated aging, a testing implementation scientist, a physician-researcher and public health leader, and a clinical development scientist behind the PURPOSE trials—addressed the questions that define the epidemic in 2026. Their answers, taken together, form an unusually coherent picture of where the field stands and where its most consequential unfinished work lies.